-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades ADC Therapeutics to Neutral

Benzinga·06/08/2026 10:32:46
Listen to the news
HC Wainwright & Co. analyst Robert Burns downgrades ADC Therapeutics (NYSE:ADCT) from Buy to Neutral.